Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Cost Effectiveness and Resource Allocation : C/E|September 24, 2014
Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysisOle F Norheim, Rob Baltussen, Mira Johri, et al.
Environmental Toxicology and Chemistry|January 10, 2006
In vivo bioassay-guided fractionation of marine sediment extracts from the Southern California Bight, USA, for estrogenic activityDaniel Schlenk, Yelena Sapozhnikova, Mary Ann Irwin, et al.
Journal of Neuromuscular Diseases|April 24, 2026
TREAT-NMD advisory committee for therapeutics: Preclinical and clinical learnings from 15 years of TACTAnnemieke Aartsma-Rus, Laura Robertson, Lindsay N Alfano, et al.
Journal for Immunotherapy of Cancer|November 2, 2021
BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonismKristen Hurov, Johanna Lahdenranta, Punit Upadhyaya, et al.
Tumori|June 21, 2008
CoCanCPG. Coordination of cancer clinical practice in EuropeBèatrice Fervers, Magali Remy-Stockinger, Valèrie Mazeau-Woynar, et al.
Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.
Lancet (London, England)|September 29, 2009
Evaluation and stages of surgical innovationsJeffrey S Barkun, Jeffrey K Aronson, Liane S Feldman, et al.
Lancet (London, England)|September 29, 2009
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch, Douglas G Altman, W Bruce Campbell, et al.
Pageof 9